G Protein-Coupled Receptor (GPCR) Expression in Native Cells: "Novel" endoGPCRs as Physiologic Regulators and Therapeutic Targets

Molecular Pharmacology
Paul A InselRoss Corriden

Abstract

G protein-coupled receptors (GPCRs), the largest family of signaling receptors in the human genome, are also the largest class of targets of approved drugs. Are the optimal GPCRs (in terms of efficacy and safety) currently targeted therapeutically? Especially given the large number (∼ 120) of orphan GPCRs (which lack known physiologic agonists), it is likely that previously unrecognized GPCRs, especially orphan receptors, regulate cell function and can be therapeutic targets. Knowledge is limited regarding the diversity and identity of GPCRs that are activated by endogenous ligands and that native cells express. Here, we review approaches to define GPCR expression in tissues and cells and results from studies using these approaches. We identify problems with the available data and suggest future ways to identify and validate the physiologic and therapeutic roles of previously unrecognized GPCRs. We propose that a particularly useful approach to identify functionally important GPCRs with therapeutic potential will be to focus on receptors that show selective increases in expression in diseased cells from patients and experimental animals.

References

Apr 8, 2003·Proceedings of the National Academy of Sciences of the United States of America·Demetrios K VassilatisGeorge A Gaitanaris
Aug 26, 2003·FEBS Letters·Yaron HakakDerek T Chalmers
Nov 20, 2003·Journal of Cell Science·Wesley K KroezeBryan L Roth
May 25, 2004·Molecular Pharmacology·Dezhong YinCraig C Malbon
Jun 14, 2005·BioTechniques·Anis H KhimaniSteven T Lott
Nov 23, 2006·Nature Methods·Arne HansenMichael J Brownstein
Dec 2, 2006·Nature Reviews. Drug Discovery·John P OveringtonAndrew L Hopkins
Jul 20, 2007·Proteomics·Matthew N DaviesDarren R Flower
Aug 10, 2007·Nature Biotechnology·Chris F TaylorHenning Hermjakob
Apr 30, 2008·Immunome Research·Jane E LattinMatthew J Sweet
Nov 6, 2008·Cell·Jean B RegardShaun R Coughlin
Jan 28, 2009·Naunyn-Schmiedeberg's Archives of Pharmacology·Martin C MichelGozoh Tsujimoto
Oct 24, 2009·FEBS Letters·Tobias MaierLuis Serrano
Dec 22, 2009·Molecular BioSystems·Raquel de Sousa AbreuChristine Vogel
Apr 29, 2010·International Journal of Data Mining and Bioinformatics·A SeckerD R Flower
May 7, 2010·The AAPS Journal·Akihiko OzawaWesley K Kroeze
Sep 25, 2010·MAbs·Catherine J HutchingsFiona H Marshall
Dec 3, 2010·Methods in Molecular Biology·Tomáš MašekMartin Pospíšek
Jan 5, 2011·Nature Reviews. Drug Discovery·Rosamaria Lappano, Marcello Maggiolini
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Apr 15, 2011·British Journal of Pharmacology·P A InselA Wilderman
Apr 10, 2012·Cell Metabolism·Frank ReimannFiona M Gribble
May 4, 2012·BJU International·Peter OchodnickýMartin C Michel
Aug 4, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Aaron N Snead, Paul A Insel
Oct 2, 2012·Annual Review of Pharmacology and Toxicology·Olivier CivelliHelgi B Schiöth
Dec 28, 2012·Nature Reviews. Genetics·Johan Rung, Alvis Brazma
Jan 8, 2013·Nature Methods·Henry LinBrian K Shoichet
Feb 15, 2013·Nature·A J VenkatakrishnanM Madan Babu
May 4, 2013·Nature Reviews. Cancer·Morgan O'HayreJ Silvio Gutkind
May 23, 2013·Pharmacology & Therapeutics·Stefan AmistenShanta J Persaud

❮ Previous
Next ❯

Citations

Aug 13, 2015·Biochemical Pharmacology·Kenneth A Jacobson
Feb 23, 2018·British Journal of Pharmacology·Jean Iyinikkel, Fiona Murray
Mar 10, 2016·Nature Communications·Katarina KlepacAlexander Pfeifer
Mar 28, 2019·Pharmacological Reviews·Terry Kenakin
Dec 9, 2017·Molecular Pharmacology·Timothy B JohnstoneRennolds S Ostrom
Jan 5, 2018·Molecular Pharmacology·Krishna Sriram, Paul A Insel
Aug 17, 2019·Science·Dandan WangKirill A Martemyanov
Nov 3, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shu Z WileyPaul A Insel
Sep 24, 2015·American Journal of Physiology. Endocrinology and Metabolism·Miles FullerBrian T Layden
Jan 29, 2021·The FEBS Journal·Mark SoaveStephen J Hill
May 13, 2019·Trends in Pharmacological Sciences·Paul A InselAmy M Chinn
Mar 20, 2018·Trends in Pharmacological Sciences·Graeme Milligan, Asuka Inoue
Jun 24, 2021·ChemPlusChem·Theresa HöfurthnerRobert Konrat
Sep 22, 2021·PloS One·Estel Aparicio-PratRobert Stanton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Methods in Molecular Biology
Richard M Eglen, Terry Reisine
Current Opinion in Pharmacology
David H RomingerJonathan D Violin
Assay and Drug Development Technologies
Ponnal Nambi, Nambi Aiyar
© 2022 Meta ULC. All rights reserved